27
KIT
VOLUNTEER!
If you like the sound of this non-invasive sensor, then help Afon by
volunteering to wear one and give feedback.
"During the product development stage we may need volunteers to
either wear a prototype device or give feedback on design or useability,"
says Afon Technology's CEO and sensor creator Sabih Chaudhry.
If you would like to help create the best version of this device, fill in
the form when you CLICK HERE.
The legacy of
GlucoWatch
Cygnus received final FDA
approval for their transdermal
glucose sensor for adults
18 years and older in March
2001. They spent over 10 years
developing this device that
measures glucose through the
skin using an AutoSensor, a
replaceable pad that clips into
the back of the GlucoWatch.
As noted at the time, sweating
and skipped readings were
problematic. When sweat
glands open up due to heat,
hypoglycemia or exercise,
the device was unable to
measure glucose. All in all, as
the first device of its kind, the
GlucoWatch was high demand
despite these problems
because no one really likes to
blood test, they just don't have
any other options.
Glossary
Electrophoresis: a laboratory
technique used to separate
DNA, RNA, or protein
molecules based on their
size and electrical charge.
An electric current is used
to move molecules to be
separated through a gel. Pores
in the gel work like a sieve,
allowing smaller molecules
to move faster than larger
molecules.
Photonics: the physical
science of light (photon)
generation, detection,
and manipulation through
emission, transmission,
modulation, signal processing,
switching, amplification,
and sensing.
for a CE mark in early 2022. Although
Covid-19 has disrupted many of our
plans, we are still pushing ahead
with product development. Our aim
is to commercialise a real time and
non-invasive blood glucose monitor
for people with diabetes which will
alert the wearer (or their carer or a
physician) when blood sugar levels
move outside set parameters. The
device will reduce the need for fiddly
and sometimes painful fingerpricks
and will give the wearer peace of
mind that they are within a safe
range. The 'working title' for the
sensor is Glucowear."
Professor de Vries, Medical
Director at Profil, the diabetes
research organisation in Germany
specialising in internal medicine
and endocrinology, and principal
investigator at the University of
Amsterdam's Faculty of Medicine,
said: "We evaluated the Afon
device under both hyper-and
hypoglycaemic (high and low blood
glucose levels) conditions during the
clinical trials and we were surprised
and excited by the possibilities of this
technology."
www.afontechnology.com
Sources
The pursuit of non-invasive glucose
testing
Mark Twain's The Deceitful Turkey
Return of the GlucoWatch
____________________________
*for more on MARD
www.ncbi.nlm.nih.gov